Haley Borthwick
Medical · Burleson, TXNPI 1003563651
Payments from drug & device makers
Across 115 payments — averaging $28.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$440
- Novartis$401
- Merck$377
- AstraZeneca$298
- E.r. Squibb & Sons, L.L.C.$298
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$237
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,244100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 23 | $440 |
| Novartis | 17 | $401 |
| Merck | 16 | $377 |
| AstraZeneca | 12 | $298 |
| E.r. Squibb & Sons, L.L.C. | 4 | $298 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $237 |
| Abiomed | 2 | $182 |
| Amgen | 9 | $162 |
| Actelion Pharmaceuticals US, Inc. | 2 | $134 |
| Chiesi USA, Inc. | 1 | $126 |
| Medtronic | 1 | $113 |
| Boston Scientific | 4 | $99 |
| Johnson & Johnson | 6 | $86 |
| Esperion Therapeutics, Inc. | 4 | $64 |
| Lexicon Pharmaceuticals, Inc. | 3 | $57 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $56 |
| Surmodics, Inc. | 2 | $36 |
| Atricure, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,244 in reported general payments places this provider in the 75th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 281 | $232,673 |
| Repatha SureclickEvolocumab | 73 | $55,798 |
| JardianceEmpagliflozin | 68 | $54,653 |
| XareltoRivaroxaban | 64 | $53,633 |
| EntrestoSacubitril/Valsartan | 39 | $34,555 |
| FarxigaDapagliflozin Propanediol | 13 | $8,758 |
| NexlizetBempedoic Acid/Ezetimibe | 18 | $7,202 |
| Ranolazine ErRanolazine | 80 | $5,571 |
| VascepaIcosapent Ethyl | 12 | $4,307 |
| Atorvastatin Calcium | 420 | $3,556 |
| Ezetimibe | 316 | $3,388 |
| Hydralazine Hcl | 298 | $2,302 |
| Rosuvastatin Calcium | 188 | $2,203 |
| Colestipol Hcl | 15 | $1,811 |
| Potassium Chloride | 136 | $1,654 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $440 | $232,673281 claims |
| Boehringer IngelheimJardiance | $15 | $54,65368 claims |
| Johnson & JohnsonXarelto | $86 | $53,63364 claims |
| NovartisEntresto | $401 | $34,55539 claims |
| AstraZenecaFarxiga | $298 | $8,75813 claims |
| Esperion Therapeutics, Inc.Nexlizet | $64 | $7,20218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,490 medical providers in Texas.
Other medical in Burleson
- Stephanie NguyenBurleson$17K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.